|
|
|
MD (Universidad de Navarra, Spain) and PhD (Universidad de Santiago de Compostela, Spain). Radiation oncology specialization at Hospital 12 de Octubre de Madrid (Spain). Clinical Research Fellow at Massachussets General Hospital, Boston (USA). He has worked as staff MD at hospital Universitario de Valladolid, Hospital Universitario de Santiago de Compostela, Hospital do Meixoeiro and as chairman at Hospital General Universitario de Ciudad Real. Currently chairman of the radiation oncology unit at Hospital Universitario de Salamanca. |
-
Glioblastoma: Does the pre-treatment geometry matter? A postcontrast T1 MRI-based study
European Radiology 27(3), 1096-1104 (2017)
J. Pérez-Beteta, A. Martínez-González, D. Molina, M. Amo, B. Luque, E. Arregui, M. Calvo, J. M. Borrás, C. López, M. Claramonte, J. Barcia, L. Iglesias, J. Avecillas, D.Albillo, M. Navarro, J.M. Villanueva, J.C. Paniagua, J. Martino, C. Velasquez, B. Asenjo, M. Benavides, I. Herruzo, M.C. Delgado, A. Del Valle, A. Falkov, P. Schucht, E. Arana, L. Pérez-Romasanta, V. M.Pérez-García -
Novel geometrical imaging biomarkers predict survival and allow for patient selection for surgery in glioblastoma patients
Neuro-Oncology 19(3):iii80-iii80 (2017)
J. Pérez-Beteta, D. Molina, A. Martínez-González, E. Arregui, B. Asenjo, L. Iglesias, J. Martino, L. Pérez-Romasanta, E. Arana, V.M. Pérez-García
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024)
|
MD (Universidad de Navarra, Spain) and PhD (Universidad de Santiago de Compostela, Spain). Radiation oncology specialization at Hospital 12 de Octubre de Madrid (Spain). Clinical Research Fellow at Massachussets General Hospital, Boston (USA). He has worked as staff MD at hospital Universitario de Valladolid, Hospital Universitario de Santiago de Compostela, Hospital do Meixoeiro and as chairman at Hospital General Universitario de Ciudad Real. Currently chairman of the radiation oncology unit at Hospital Universitario de Salamanca. |
- Glioblastoma: Does the pre-treatment geometry matter? A postcontrast T1 MRI-based study
European Radiology 27(3), 1096-1104 (2017)
J. Pérez-Beteta, A. Martínez-González, D. Molina, M. Amo, B. Luque, E. Arregui, M. Calvo, J. M. Borrás, C. López, M. Claramonte, J. Barcia, L. Iglesias, J. Avecillas, D.Albillo, M. Navarro, J.M. Villanueva, J.C. Paniagua, J. Martino, C. Velasquez, B. Asenjo, M. Benavides, I. Herruzo, M.C. Delgado, A. Del Valle, A. Falkov, P. Schucht, E. Arana, L. Pérez-Romasanta, V. M.Pérez-García - Novel geometrical imaging biomarkers predict survival and allow for patient selection for surgery in glioblastoma patients
Neuro-Oncology 19(3):iii80-iii80 (2017)
J. Pérez-Beteta, D. Molina, A. Martínez-González, E. Arregui, B. Asenjo, L. Iglesias, J. Martino, L. Pérez-Romasanta, E. Arana, V.M. Pérez-García
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024)
